Skip to main content
Search
Newsletters
Watchlist
Home
Watchlist
For You
Canada
World
Business
Investing
Personal Finance
Opinion
Politics
Sports
Life
Arts
Drive
Real Estate
Latest in
TSX Today:
ENB-T
-0.04%
MFC-T
+1.06%
GWO-T
+0.35%
SU-T
+0.76%
CVE-T
+1.14%
FTS-T
-0.13%
TD-T
+0.62%
Search stocks, ETFs and Commodities
Instrument Name
Equillium Inc
Instrument Symbol
(EQ-Q)
Instrument Exchange
NASDAQ
Add to Watchlist
Create Alerts
USD
Today's Change
Real-Time
Last Update
Last Sale
Cboe BZX Real-Time
USD
After Hours
Change
After Hours
Last Update
After Hours
Price
Volume
Summary
Charts
Profile
Financials
Statistics
Dividends
Price History
Analyst Estimates
Insiders
Equillium Inc
2223 Avenida de la Playa Suite 105
LA JOLLA CA 92037 USA
P:
858-240-1200
http://www.equilliumbio.com
Sectors & Indices
Sector
Industry
Employees
SIC-2834 Pharmaceutical Preparations
Medical - Biomedical
Profile
Equillium, Inc. is a biotechnology company. It develops products for autoimmune and inflammatory disorders. The company's product pipeline consists of EQ001 which is in clinical-stage. Equillium, Inc. is based in CA, United States.
Key Executives
Name
Title
Bruce D. Steel
CEO/Co-Founder/Director/President
Jason A. Keyes
CFO/Chief Accounting Officer
Stephen Connelly
Chief Scientific Officer/Co-Founder/Director
Christine Zedelmayer
COO/Senior VP
More from The Globe
Dividend investing has lost its mojo. Here’s why – and how to adapt
Ian McGugan
May 17, 2024
The Globe Investing Club 2024: Let the competition begin!
May 17, 2024
opinion
Here’s the real reason your Canadian stocks can’t keep up
Tim Shufelt
May 17, 2024
Dow ends above 40,000 milestone, TSX also at fresh record high
May 17, 2024
number cruncher
U.S technology stocks with earnings and price momentum
May 16, 2024
Lightspeed Commerce stock soars on better-than-expected profit forecast
May 16, 2024
GameStop, AMC dive further as meme stocks rally tapers off
May 16, 2024
The close: Dow briefly hits 40,000 milestone, TSX rises on upbeat earnings
May 16, 2024